High glucose-induced TGF-β1 regulates mesangial production of heparan sulfate proteoglycan

American Journal of Physiology

Volumn 270, Issue 5 PART 2, 1996, Pages

  Kolm, Verena ^a   Sauer, Ulrich ^a   Olgemöller, Bernhard ^a   Schleicher, Erwin D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLUCOSE; PERLECAN; PROTEOHEPARAN SULFATE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE;

ANIMALS; AORTA; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; FIBRONECTINS; GLOMERULAR MESANGIUM; GLUCOSE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; OLIGONUCLEOTIDES, ANTISENSE; OSMOLAR CONCENTRATION; POLYMERS; PROTEOGLYCANS; RNA, MESSENGER; SWINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029924863     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ayo, S. H., R. A. Radnik, W. F. Glass, J. A. Garoni, E. R. Rampt, D. R. Appling, and J. I. Kreisberg. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am. J. Physiol. 260 (Renal Fluid Electrolyte Physiol. 29): F185-F191, 1991.
2. Battaglia, C., U. Mayer, M. Aumailley, and R. Timpl. Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Ear. J. Biochem. 208: 359-366, 1992.
3. Battegay, E. J., E. W. Raines, R. A. Seifert, D. F. Bowen Pope, and R. Ross. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63: 515-524, 1990.
4. Border, W. A., S. Okuda, L. R. Languino, and E. Ruoslahti. Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int. 37: 689-695,1990.
5. Chen, R. H., R. Ebner, and R. Derynck. Inactivation of the type receptor reveals two receptor pathways for the diverse TGF-beta activities. Science Wash. DC 260: 1335-1338, 1993.
6. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
7. Coimbra, T., R. Wiggins, J. W. Noh, S. Merritt, and S. H. Phan. Transforming growth factor-beta production in antiglomerular basement membrane disease in the rabbit. Am. J. Pathol. 138: 223-234, 1991.
8. D'Amore, P.A. Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev. 9: 227-238, 1990.
9. Danielpour, D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J. Immunol. Methods 158: 17-25, 1993.
10. Doi, T., H. Vlassara, M. Kirstein, Y. Yamada, G. E. Striker, and L. J. Striker. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sei. USA 89: 2873-2877, 1992.
11. Farquhar, M. G. The glomerular basement membrane - a selective macromolecular filter. In: Cell Biology of the Extracellular Matrix, edited by E. Hay. New York: Plenum, 1991, p. 365-418.
12. Flyvbjerg, A. Growth factors, and diabetic complications. Diabet. Med. 7: 387-399, 1990.
13. Fukui, M., T. Nakamura, I. Ebihara, I. Shirato, Y. Tomino, and H. Koide. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41: 1520-1527, 1992.
14. Guretzki, H. J., K. D. Gerbitz, B. Olgemoller, and E. Schleicher. Atherogenic level of low density lipoprotein alter the permeability and composition of the endothelial barrier. Atherosclerosis 107: 15-24, 1994.
15. Guretzki, H. J., E. D. Schleicher, K. D. Gerbitz, and B. Olgemoller. Influence of extracellular matrix in heparininduced increase in endothelial permeability. Am. J. Physiol. 267 (Cell Physiol. 36): C946-C954, 1994.
16. Ignotz, R. A., T. Endo, and J. Massague. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J. Biol. Chem. 262: 6443-6446, 1987.
17. Kondaiah, P., E. Van Obberghen Schilling, R. L. Ludwig, R. Dhar, M. B. Sporn, and A. B. Roberts. cDNA cloning of porcine transforming growth factor-beta 1 mRNAs. Evidence for alternate splicing and polyadenylation. J. Biol. Chem. 263: 18313-18317, 1988.
18. Kreisberg, J. I., and S. H. Ayo. The glomerular mesangium in diabetes mellitus. Kidney Int. 43: 109-113, 1993.
19. Nakamura, T., M. Fukui, I. Ebihara, S. Osada, I. Nagaoka, Y. Tomino, and H. Koide. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42: 450-456, 1993.
20. Nerlich, A., and E. Schleicher. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am. J. Pathol. 139: 889-899, 1991.
21. Olgemoller, B., E. Schleicher, A. Nerlich, E. M. Wagner, and K. D. Gerbitz. Isolation, characterization and immunological determination of basement membrane-associated heparan sulfate proteoglycan. Biol. Chem. Hoppe Seyler 370: 1321-1329, 1989.
22. Olgemoller, B., E. D. Schleicher, S. Schwaabe, H. J. Guretzki, and K. D. Gerbitz. High concentrations of low density lipoprotein decrease basement membrane-associated heparan sulfate proteoglycan in cultured endothelial cells. FEBS Lett. 264: 37-39, 1990.
23. Olgemoller, B., S. Schwaabe, K. D. Gerbitz, and E. D. Schleicher. Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia 35: 183-186, 1992.
24. Osterby, R., M. A. Gall, A. Schmitz, F. S. Nielsen, G. Nyberg, and H. H. Parving. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1064-1070, 1993.
25. Pugliese, G., F. Pricci, F. Pugliese, P. Mené, L. Lenti, D. Andreani, G. Galli, A. Casini, S. Blanchi, C. M. Rotella, and U. DiMario. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43: 478-490, 1994.
26. Roberts, A. B., B. K. McCune, and M. B. Sporn. TGF-beta: regulation of extracellular matrix. Kidney Int. 41: 557-559, 1992.
27. Schleicher, E. D., E. M. Wagner, B. Olgemoller, A. G. Nerlich, and K. D. Gerbitz. Characterization and localization of basement membrane-associated heparan sulfate proteoglycan in human tissues. Lab. Invest. 61: 323-332,1989.
28. Shimomura, H., and R. G. Spiro. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36: 374-381, 1987.
29. Silbiger, S., S. Crowley, Z. Shan, M. Brownlee, J. Satriano, and D. Schlondorff. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int. 43: 853-864, 1993.
30. Steffes, M. W., R. W. Bilous, D. E. Sutherland, and S. M. Mauer. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41: 679-684, 1992.
31. Striker, G. E., and L. J. Striker. Glomerular cell culture. Lab. Invest. 53: 122-131,1985.
32. Tamsma, J. T., J. van den Born, J. A. Bruijn, K. J. Assmann, J. J. Weening, J. H. Berden, J. Wieslander, E. Schrama, J. Hermans, J. H. Veerkamp, H. H. P. Lemkes, and F. J. van der Woude. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320, 1994.
33. Van, den Born, J., L. P. van den Heuvel, M. A. Bakker, J. H. Veerkamp, K. J. Assmann, and J. H. Berden. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int. 41: 115-123, 1992.
34. West, D. C., A. Sattar, and S. Kumar. A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal. Biochem. 147: 289-295,1985.
35. Wolf, G., K. Sharma, Y. Chen, M. Ericksen, and F. N. Ziyadeh. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int. 42: 647-656, 1992.
36. Wright, T. C., J. J. Castellot, J. R. Diamond, and M. J. Karnovsky. Regulation of cellular proliferation by heparin and heparan sulfate. In: Heparin, edited by D. A. Lane and U. Lindahl. London: Arnold, 1989, p. 295-316.
37. Yamamoto, T., T. Nakamura, N. A. Noble, E. Ruoslahti, and W. A. Border. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sei. USA 90: 1814-1818, 1993.
38. Ziyadeh, F. N. The extracellular matrix in diabetic nephropathy. Am. J. Kidney Dis. 22: 736-744, 1993.
39. Ziyadeh, F. N., K. Sharma, M. Ericksen, and G. Wolf. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J. Clin. Invest. 93: 536-542, 1994.